We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -1.27% | 39.00 | 38.50 | 39.50 | 39.50 | 38.50 | 39.50 | 285,898 | 15:55:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 95.12 | 49.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/3/2022 13:09 | Yup GLA tomorrow! | qs99 | |
23/3/2022 10:20 | You might not have long to wait as it is results day tomorrow | basem1 | |
23/3/2022 09:49 | I filled my boots with these the last few days. I'm hoping for a nice recovery in the share price and get some of the money I lost here a year or so ago. | pngasef | |
22/3/2022 07:43 | Good news from Alliance Pharma's results this morning since VLG are a manufacturing partner for Kelo-cote: "Kelo-cote - scar prevention and treatment Kelo-cote delivered another excellent performance, particularly in the APAC region, generating revenues of GBP48.8m, up 41% on the prior year (2020: GBP34.7m). CER revenues were up 47% due to continued strong demand from China, reflecting the growth of both domestic sales and significant cross-border e-commerce ("CBEC") sales. Kelo-cote is very well established in China, with high brand awareness and usage. The growth in domestic and CBEC revenues reflects the increasing trend for consumers in China and elsewhere to migrate more to online purchasing, both of the brand itself, and healthcare products generally - a trend accelerated by the global pandemic." | rivaldo | |
18/3/2022 15:02 | 40p full offer being paid lovely job | qs99 | |
18/3/2022 14:02 | Not far off buying at full offer, then we may zoom back to 50p IMO....DYOR | qs99 | |
18/3/2022 13:42 | Moving along nicely ahead of results next week DYOR | qs99 | |
18/3/2022 11:49 | Far too cheap Impressive latest half year sales here Add whilst you can in the 30's | basem1 | |
22/2/2022 14:09 | Regarding the mouthwash COVID claim - does it not strike anyone as odd that it's taken from Nov'20 to Feb'22 to get this updated from an in-vitro / test-tube study to a 78 person stage 1 clinical trial. If there was some real commercial application or market for this it would have taken flight months ago. The study data has still not been peer-reviewed. It just appears like more infomercial news/noise. What's the materiality of this news really? I would rather they provide some update on progress with the new acquisitions or on the Samarkand - Chinese market deal. I guess all will be revealed 24th March. We really need to have a comprehensive update at the finals to dispel the doubters and rebuild confidence amongst shareholders and the wider investment community. | isf7boa | |
21/2/2022 08:11 | I think personally that’s big news, will be interesting to see if the market notices it, that’s a great piece of marketing potential | csmwssk12hu | |
21/2/2022 07:45 | Nice that they finally got their research paper out showing that their mouth rinse has an inhibitory effect on covid. I wonder if the bottles of mouth rinse will now claim this fact? Could be useful and valuable going forward! | pngasef | |
07/2/2022 10:46 | Thanks Riv, maybe some left over buying from the tip then..... Final results update, will hopefully chug this further along to his £1 target ....DYOR Cheers QS99 | qs99 | |
07/2/2022 10:16 | Simon Thompson tipped VLG on 31st January as follows (not posted here before): "Penny drops with Venture Life Share price rises 36 per cent following pre-close trading update Order book significantly ahead of the same time last year The recovery at Aim-traded Venture Life (VLG:51p), a developer, manufacturer and distributor of products for the self-care markets, is gathering traction. A pre-close trading update for the year just ended was in line with my financial analysis three weeks ago when I made the case to buy the shares, at 40p (‘Venture Life’s recovery potential revealed, 10 January 2021). Of more importance is news that the order book is “significantly ahead of the same time last year”, shipments with new China distribution partner have started, and two UK health and beauty retailers will be launching Venture’s lesser known in-house brands (for rosacea, women’s intimate gel, and wart & varruca pen) under their own labels. The group is also progressing an aggressive expansion plan for prostrate cancer management product Pomi-T. Priced on a forward PE ratio of 11 for 2022, I maintain my 100p target. Buy." | rivaldo | |
07/2/2022 09:28 | Are we expecting news soon? Not massive volume, but looking pretty determined iMO to get through 50p! Let's see....DYOR | qs99 | |
07/2/2022 09:13 | thanks Brummy.....nice moves this am, your SPV having effect | qs99 | |
04/2/2022 16:18 | Justin & I talk about Venture Life starts 21:35) here in today's Stock Picking video. www.youtube.com/watc | brummy_git | |
01/2/2022 10:43 | quite few buy's are showing in sell column this morning | ak62 | |
01/2/2022 09:24 | Anyone know what the analyst forecasts are for 2022? | stemis | |
01/2/2022 09:16 | One quiet board today, so from trading update they are currently hitting around £1m per week sales, running profitably and have more product launches due to hit, final results 24th March, this may have pull backs like this morning but the graph says it turned, the trading statement says it’s turned, I would expect this to climb until the 24th March when if followed by similar good news another pop, I’m no long term holder in anything unless I think it has further to run and this has imho dyor gla | csmwssk12hu | |
01/2/2022 00:46 | Lot of potential here imho | csmwssk12hu | |
01/2/2022 00:45 | And closed at high of day | csmwssk12hu | |
01/2/2022 00:45 | Little burst of buys into close looks good for strong start in morning | csmwssk12hu | |
31/1/2022 17:20 | ST still maintains 100p price target today | toptomcat | |
31/1/2022 14:23 | Another tiddler on the move from last week low is B90 online gambling business, quite apt really, yes QS I can see this one getting into triple figures in the future all imho dyor | csmwssk12hu | |
31/1/2022 13:51 | Great thanks for the v. informative posts. SteMis I would agree, also any +Ve sales flow news from China or further deals should add to the mix IMO....continued delivery should help them drive a higher rating once more IMO. Lots to play for, glad I topped up and if management can put last year's fiasco behind them, no reason we shouldn't see North of a quid in H1 if market looks 12 months ahead IMO....DYOR Cheers QS99 | qs99 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions